The Effect of Structured Transition Care Model Applied to Adolescents With Congenital Heart Disease
NCT ID: NCT06433401
Last Updated: 2025-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2024-08-29
2025-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Studies have shown that both adolescents with congenital heart disease and their caregivers need professional support, appropriate transition education and care before transition to adult care in order to increase adaptation to adult care, to gain self-management skills and to reduce their concerns. Studies in which adolescents are followed up after transition to adult care show that when the transition process is not successfully completed, there is excessive time between the last pediatric control and the first adult control or there are losses in further follow-up. Although there are studies in our country in which transition care is applied, this study is planned because there is no intervention study in which developmental transition care model is applied to adolescents with congenital heart disease. It is thought that this study will increase the transition readiness levels, self-management skills and care satisfaction of adolescents with congenital heart disease and guide the nurses working with them.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Growth and Development of Children With Congenital Heart Disease (CHD)
NCT04903964
Cardiovascular Health and Nursing Interventions in 6th Grade Middle School Children
NCT06812156
The Effect of Preparatory Education on Parental Stress and Attitudes in Parents of Children Entering Early Adolescence
NCT06568068
Discharge Education And Telephone Counseling in Pediatric Cardiac Surgery Patients
NCT06998186
The Effect of Transition to Adulthood Education Program on Family Quality of Life and Perceived Stress Level
NCT05587647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of transitional care is to maintain the control and well-being of the disease in adulthood and maximize its potential by providing the quality care practices needed by the adolescent without interruption. Studies have shown that both adolescents with congenital heart disease and their caregivers need professional support, appropriate transition education and care before transition to adult care in order to increase their adaptation to adult care, gain self-management skills and reduce their concerns. The American Academy of Pediatrics (APA) recommends that the transition process should begin with transition planning between the ages of 12-14. However, since physiological and psychological development and needs are not related to the chronological age of the individual, the essence of timing in the transition process is flexibility. The timing of transition varies depending on many individual and environmental variables such as age, gender, physical and psychological maturation, current medical condition, compliance and adherence to treatment, readiness of the adolescent for transition, finding an appropriate adult care provider, and insurance policies. In studies in which adolescents with congenital heart disease were followed up after transition to adult care, when the transition process was not successfully completed, there was a gap between the last pediatric control and the first adult control. In conclusion, there is no intervention study in our country in which the developmental transition care model was applied to adolescents with congenital heart disease and the results were evaluated. In addition, based on clinical experiences and observations, it was determined that adolescents and their parents had difficulties in the transition from pediatric care to adult care and this negatively affected self-management related to the disease. The aim of this study was to evaluate the effect of the developmental transition care model applied to adolescents with congenital heart disease during the transition from pediatric care to adult care on the transition readiness level, self-management skills and care satisfaction of adolescents.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transition care group
The transitional care group is a group that will receive a transitional care training consisting of a total of 3 modules in which the content is arranged for individualized needs with expert opinion from 10 faculty members working in the field of Child Health and Diseases Nursing.The education sessions will be conducted every months in sessions of approximately 35-40 minutes face-to-face in the training room allocated to the individual researcher.
Transitional care training with brochures, posters and slide training materials
Education at 1 and 2 months after the first interview
Control group
The control group is the group receiving routine care that continues the normal follow-up of the clinic without any intervention. However, in terms of compliance with ethical principles, the same training will be given to them upon their request after the research is completely completed.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transitional care training with brochures, posters and slide training materials
Education at 1 and 2 months after the first interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To be between the ages of 16-20,
* Having a diagnosis of congenital heart disease,
* Being followed up with a diagnosis of congenital heart disease for at least one year in the polyclinics where the study was conducted,
* To be able to communicate in Turkish,
* Not having any mental deficiency that may prevent communication
Exclusion Criteria
* Not being able to communicate in Turkish,
* Not showing up regularly for follow-ups,
* Having any mental disability that may prevent communication
16 Years
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Yildirim Beyazıt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
tutkukırçı
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tutku KIRÇI TEMİZ, PhD s.
Role: PRINCIPAL_INVESTIGATOR
Ankara Yildirim Beyazıt University
Evrim KIZILER, Asst.Prof.
Role: STUDY_DIRECTOR
Ankara Yildirim Beyazıt University
Utku ARMAN ÖRÜN, Prof.Dr.
Role: STUDY_DIRECTOR
Republic of Turkey Ministry of Health Ankara Etlik City Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Republic of Turkey Ministry of Health Ankara Etlik City Hospital
Ankara, Ankara Yenimahalle, Turkey (Türkiye)
Republic of Turkey Ministry of Health Ankara Etlik City Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AnkaraYBU-SBF-TKT-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.